Medicare Enrolled
Dr. Juan Estigarribia
Endocrinology · Dearborn, MI
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Estigarribia from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Estigarribia?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Estigarribia
Dr. Juan Estigarribia is an endocrinology specialist in Dearborn, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Estigarribia performed 3,181 Medicare services across 1,393 unique beneficiaries.
Between the years covered by Open Payments, Dr. Estigarribia received a total of $3,625 from 38 pharmaceutical and/or device companies across 217 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Estigarribia is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 7% volume in MI
$3,625 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,181
Medicare services
Top 7% in MI for endocrinology
1,393
Unique beneficiaries
$55
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~159 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 1,080 | $18 | $33 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
717 | $93 | $200 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
151 | $69 | $165 |
| Ultrasound of head and neck soft tissue This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation. |
119 | $64 | $193 |
| Blood glucose level test A test that measures the amount of sugar in your blood. |
107 | $4 | $10 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
91 | $11 | $40 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
79 | $86 | $377 |
| Complete ultrasound of brain blood flow An ultrasound test that evaluates blood flow within the brain's blood vessels. It uses sound waves to create images of the vessels and assess circulation. |
79 | $175 | $586 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
79 | $130 | $173 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
77 | $9 | $50 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
70 | $38 | $78 |
| Annual depression screening | 69 | $18 | $29 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
65 | $95 | $293 |
| Quadrivalent influenza vaccine, cell culture-derived A flu shot that protects against four strains of the influenza virus. It is produced using cell culture technology rather than traditional egg-based methods. |
63 | $32 | $50 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
63 | $31 | $40 |
| Complete ultrasound of abdomen A diagnostic imaging test that uses sound waves to create detailed pictures of the organs and structures within the abdomen. |
43 | $60 | $300 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
42 | $1 | $20 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
29 | $64 | $111 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
26 | $137 | $315 |
| Ultrasound of leg arteries or grafts An imaging test that uses sound waves to create pictures of the blood vessels in the legs or any surgical grafts present. |
24 | $156 | $398 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
21 | $117 | $262 |
| Ultrasound-guided fine needle aspiration biopsy, first lesion A biopsy procedure where a thin needle is used to collect tissue samples from a growth, guided by ultrasound imaging. This code applies to the first lesion or mass sampled during the session. |
19 | $111 | $350 |
| Thyroid needle biopsy A procedure in which a thin needle is inserted through the skin into the thyroid gland to remove a small sample of tissue for examination. |
19 | $43 | $179 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
19 | $45 | $350 |
| Ultrasound of arm and leg arteries This procedure uses sound waves to create images of the blood vessels in the arms and legs. It allows healthcare providers to examine the structure and blood flow within these arteries. |
16 | $42 | $150 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
14 | $217 | $363 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.0% high complexity
51.2% medium
46.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$3,625
Total received (2018-2024)
Avg $518/year across 7 years
Top 40% in MI for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
38
Companies
217
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,625 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$483
2023
$502
2022
$521
2021
$673
2020
$456
2019
$638
2018
$352
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Dexcom, Inc.
$94
Novo Nordisk Inc
$64
Amgen Inc.
$64
Lilly USA, LLC
$56
Xeris Pharmaceuticals, Inc.
$36
Nevro Corp.
$31
Neurocrine Biosciences, Inc.
$28
Tandem Diabetes Care, Inc.
$25
Amneal Pharmaceuticals LLC
$23
RECORDATI_RARE_DISEASES_INC.
$22
Chiesi USA, Inc.
$20
Corcept Therapeutics
$20
Top 3 companies account for 45.9% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$682
Lilly USA, LLC
$482
Amgen Inc.
$303
Amarin Pharma Inc.
$279
SANOFI-AVENTIS U.S. LLC
$236
Xeris Pharmaceuticals, Inc.
$207
AstraZeneca Pharmaceuticals LP
$153
Insulet Corporation
$130
Dexcom, Inc.
$113
Abbott Laboratories
$99
Corcept Therapeutics
$94
Amneal Pharmaceuticals LLC
$93
Shire North American Group Inc
$74
Merck Sharp & Dohme Corporation
$46
IBSA Pharma Inc.
$45
Exact Sciences Corporation
$41
Novartis Pharmaceuticals Corporation
$41
Ultragenyx Pharmaceutical Inc.
$36
Janssen Pharmaceuticals, Inc
$34
Mannkind Corporation
$33
Endo Pharmaceuticals Inc.
$33
Bayer HealthCare Pharmaceuticals Inc.
$31
Nevro Corp.
$31
LIFESCAN, INC.
$29
Neurocrine Biosciences, Inc.
$28
Tandem Diabetes Care, Inc.
$25
DEXCOM, INC.
$24
Medtronic MiniMed, Inc.
$24
LifeScan, Inc.
$23
RECORDATI_RARE_DISEASES_INC.
$22
Esperion Therapeutics, Inc.
$21
Chiesi USA, Inc.
$20
Medtronic, Inc.
$18
Rhythm Pharmaceuticals, Inc.
$18
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$18
Becton, Dickinson and Company
$14
Aegerion Pharmaceuticals, Inc.
$14
Kowa Pharmaceuticals America, Inc.
$13
Top 3 companies account for 40.5% of all-time payments
Associated products mentioned in payments ›
AFREZZA · BAQSIMI · BD NANO · CYCLOSET · Cologuard Collection Kit · DEXCOM G6 TRANSMITTER · Dexcom G6 Transmitter · EVENITY · FARXIGA · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE HYPOPEN · GVOKE PFS · HUMULIN · INVOKANA · JANUVIA · JARDIANCE · JUXTAPID · Kerendia · Korlym · LEQVIO · Livalo · MINIMED 780G · MOUNJARO · MYCAPSSA · Macrilen · Minimed 670G System · NASCOBAL · NATPARA · NATPARA (PARATHYROID HORMONE) · NEXLETOL · ONETOUCH VERIO FLEX · ONETOUCH VERIO REFLECT · Omnipod · OneTouch Verio Reflect · Ozempic · Prolia · RECORLEV · RYBELSUS · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · Senza · TOUJEO · TRULICITY · Tirosint · Tresiba · UNITHROID · Vascepa · Victoza · XARELTO · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Endocrinologists within 10 mi
97
Per 100K population
5.5
County median income
$59,521
Nearest hospital
BEAUMONT HOSPITAL - DEARBORN
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Estigarribia is a clinical cardiology specialist, with above-average Medicare volume (top 7% in MI), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Estigarribia experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Estigarribia performed 1,080 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Estigarribia receive payments from pharmaceutical companies?
Yes. Dr. Estigarribia received a total of $3,625 from 38 companies across 217 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Estigarribia's costs compare to other endocrinologists in Dearborn?
Dr. Estigarribia's average Medicare payment per service is $55. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Estigarribia) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in Dearborn
Browse endocrinologists in Dearborn ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in MI
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in MI
Which MI endocrinologists receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology